Trinity Biotech’s Chief Technology Officer, Dr Gary Keating, added, “Our next phase of refinements, guided by this study’s positive results, will be tested in a second European pre-pivotal ...

Trinity Biotech (TRIB) has released an update. Trinity Biotech reported a 3% increase in Q3 2024 revenue to $15.2 million, driven by strong dema ...

While Trinity Biotech plc (NASDAQ:TRIB) might not be the most widely known stock at the moment, it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGS. As a ...